Assyro AI

FDA Orange Book · active-ingredient family

Halothane

Halothane is approved as 1 brand and 3 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.

Reference-listed drug:FLUOTHANE · NDA 011338

1

Brand (NDA)

3

Generics (ANDA)

0

Listed patents

0

Exclusivity periods

Brand (NDA) products · liquid

ProductApplicantApplicationTEApproved
FLUOTHANEWYETH AYERSTNDA 011338Approved Prior to Jan 1, 1982

Generic (ANDA) products (3)

ProductApplicantApplicationTEApproved
HALOTHANEBHANDA 084977Approved Prior to Jan 1, 1982
HALOTHANEHALOCARBONANDA 080810Approved Prior to Jan 1, 1982
HALOTHANEHOSPIRAANDA 083254Approved Prior to Jan 1, 1982

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Halothane — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.